alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › retinal-biomarkers

retinal-biomarkers

3 studies tagged retinal-biomarkers, dated 2020-01-01 to 2021-05-14. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis 2021-05-14
  2. Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis 2020-10-04
  3. Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward 2020-01-01

Studies

3 studies carry this tag.

Date range

2020 to 2021

Top journals

  • Ageing research reviews 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • GeroScience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Ageing research reviews 2021-05-14 Brain scans and imaging

    Retinal structural, vascular, and electrophysiological biomarkers hold great potential for the diagnosis, prognosis and risk assessment of AD and MCI.

  2. Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. GeroScience 2020-10-04 Brain scans and imaging

    Cognitive impairment and dementia are major medical, social, and economic public health issues worldwide with significant implications for life quality in older adults.

  3. Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2020-01-01 Brain scans and imaging

    The last decade has seen a substantial increase in research focused on the identification, development, and validation of diagnostic and prognostic retinal biomarkers for Alzheimer's disease (AD).

All topic tags with their study counts